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Risk assessment documentation in COC prescribing
Documentation is important in the everexpanding defensive medicine culture, particularly when prescribing medication. As a female Foundation 2 Doctor in General Practice, I see many women for routine contraceptive pill checks. I was surprised to find that very few consultations documented a risk assessment when the pill was first prescribed, considering factors that are very clearly outlined in the British National Formulary (BNF). In response to this observation I audited the initial consultations of combined oral contraceptive pill (COC) prescribing to review the documentation of a risk assessment in general practice. The audit served to quantify the standard of medical record keeping and act as a reminder of the risk involved in prescribing the COC. As a result, measures have been taken to improve record keeping in this area, and in turn improve clinical care. Consequently I felt it was an interesting and relevant topic for discussion. Recording a full risk assessment prior to prescribing the COC is difficult within the time constraints of general practice. However, before prescribing a hormonal method of contraception it is the clinician's responsibility to determine and record any contraindications to use in the individual. Clear guidelines exist for prescribing the COC in the BNF 1 and World Health Organization Medical Eligibility Criteria (WHOMEC) 2 and in particular, recognise a risk among women with a personal or family history (FH) of venous thromboembolism (VTE). 3 An audit carried out in a surgery in North Derbyshire to review the documentation of risk during the first issue of the COC demonstrated poor performance in this area. Of the 134 women audited, only 4% of consultations documented specifically 'no FH of VTE' and 14% included a broad statement like 'no contraindications'. The remaining 82% of consultations made no mention of a risk assessment. A negative personal history of VTE was recorded in 1% of consultations and a further 21% made a general comment with reference to past medical history. The BNF parameters of height, weight, body mass index, smoking status and blood pressure were only completed in 24% of consultations and only 3% included all of these five parameters and had a broad statement regarding risk, for example 'no contraindications'. No consultations included a specific statement about VTE risk, personal or within the family, and all of these parameters.
With the increasing emphasis on defensive medicine, documentation needs to be improved to protect the practitioner and demonstrate the patient gave fully informed consent. In cases where clear guidelines exist on prescribing, general practitioners should ensure their computer templates offer relevant prompts for questioning to allow rapid, complete documentation of the consultation. Ultimately it is the responsibility of the prescriber to ensure that risks do not outweigh the benefits and, if in doubt, consider alternatives.
